Olanzapine for Prevention of Chemotherapy-induced Nausea and Vomiting in Children: A Multi-Centre Feasibility Study
Phase of Trial: Phase II
Latest Information Update: 03 Oct 2016
Price : $35 *
At a glance
- Drugs Olanzapine (Primary)
- Indications Chemotherapy-induced nausea and vomiting
- Focus Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 26 Sep 2016 Status changed from active, no longer recruiting to completed.
- 19 Jan 2016 Status changed from recruiting to active, no longer recruiting as per ClinicalTrials.gov record.